Le Fel Johan, Daireaux Aurélie, Vandenbosshe Sandrine, Heutte Natacha, Rigal Olivier, Rovira Katia, Joly Florence, Roy Vincent
EA4700, université de Rouen, laboratoire PSY-NCA, rue Lavoisier, 76821 Mont-Saint-Aignan cedex, France.
Bull Cancer. 2013 Mar;100(3):223-9. doi: 10.1684/bdc.2013.1710.
Cancer and chemotherapy can have adverse effects on cognitive functions and quality of life of patients. We wanted to know the patients' view on these disorders, but also their expectations in terms of assessment and support.
A survey was conducted in day care hospital among 551 patients from three cancer centers. Most of the patients were between 40 and 74 years and suffered from breast cancer. Eighty-four percent were treated with chemotherapy. Forty-one percent of patients report memory problems, 26% were affected by specific concentration disorders, and 19% of the attention. On the whole, 52% of patients report at least one of the previous cognitive impairment. Among these patients, 80% evoked that the support of these problems was essential and 70% were willing to participate in "workshops" to deal with these disorders.
The cognitive impairment occurrence is a real problem for patients receiving chemotherapy and becomes a priority in the global management of their disease. Studies assessing a specific support of theses symptoms should be encouraged to help patients.
癌症和化疗会对患者的认知功能和生活质量产生不利影响。我们想了解患者对这些疾病的看法,以及他们在评估和支持方面的期望。
在日间护理医院对来自三个癌症中心的551名患者进行了一项调查。大多数患者年龄在40至74岁之间,患有乳腺癌。84%的患者接受了化疗。41%的患者报告有记忆问题,26%的患者受到特定注意力障碍的影响,19%的患者存在注意力问题。总体而言,52%的患者报告至少有上述认知障碍中的一种。在这些患者中,80%的人认为解决这些问题至关重要,70%的人愿意参加“工作坊”来应对这些疾病。
认知障碍的发生对接受化疗的患者来说是一个实际问题,并且成为其疾病整体管理中的一个优先事项。应鼓励开展评估这些症状特定支持措施的研究,以帮助患者。